Clinical Trials Logo

Colorectal Liver Metastasis clinical trials

View clinical trials related to Colorectal Liver Metastasis.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05753163 Recruiting - Clinical trials for Colorectal Liver Metastasis

Hepatic Arterial Infusion Chemotherapy Combined With Sintilimab and Regorafenib as Adjuvant Therapy for Colorectal Liver Metastasis Patients With a High Risk of Recurrent: a Single-arm, Phase II Study

Start date: August 2, 2022
Phase: Phase 2
Study type: Interventional

Pts with histologically confirmed CRLM and whose CRS >2 were enrolled into this single-arm, phase II study. The critical enrollment criteria were that Subjects had completely resected Primary lesion and liver metastases and had no evidence of extrahepatic disease. After hepatectomy, HAIC (FOLFOX: oxaliplatin 85mg/m2, 5- fluorouracil 2500mg/m2, calcium folinate 400mg/m2) was given every 4-6 weeks for 2-4 cycles depending on pts' health status, in combination with Sintilimab (200mg, iv, d1) and regorafenib (80mg, po, d1-21) every 3 weeks for up to 6 months. The primary endpoint was 1-year recurrence-free survival (RFS) and secondary endpoints included RFS, overall survival (OS), safety, and health-related quality of life.

NCT ID: NCT04678583 Recruiting - Clinical trials for Colorectal Liver Metastasis

Anatomical Resection of Liver MetAstases iN patIents With RAS-mutated Colorectal Cancer

ARMANI
Start date: January 1, 2021
Phase: N/A
Study type: Interventional

the ARMANI trial will test the hypothesis, if an anatomic resection (AR) improves long-term outcome vs. a non-anatomical resection (NAR) in patients undergoing surgery for RAS-mutated colorectal liver metastasis (CRLM).

NCT ID: NCT03895723 Recruiting - Clinical trials for Colorectal Liver Metastasis

Minimally Invasive Versus Open Liver Resection for Patients With Colorectal Cancer Liver Metastases

Start date: March 1, 2019
Phase: N/A
Study type: Interventional

To examine survival of patients who underwent minimally invasive versus open liver resection for colorectal cancer with liver metastases.

NCT ID: NCT02642978 Recruiting - Clinical trials for Colorectal Liver Metastasis

Robot-assisted Procedure Versus Open Simultaneous Resection of Colorectal Cancer With Liver Metastases

Start date: September 1, 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the safety and effectiveness of robot-assisted simultaneous resection in selected patients with sigmoid colon cancer or rectal cancer liver metastases, and compared with the traditional open procedure.